Barclays’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.97M | Buy |
|
|||||
|
2025
Q1 | $855K | Sell |
|
|||||
|
2024
Q4 | $982K | Buy |
|
|||||
|
2024
Q3 | $1.22M | Buy |
|
|||||
|
2024
Q2 | $561K | Sell |
|
|||||
|
2024
Q1 | $1.04M | Sell |
|
|||||
|
2023
Q4 | $2.01M | Buy |
|
|||||
|
2023
Q3 | $1.35M | Sell |
|
|||||
|
2023
Q2 | $1.8M | Buy |
|
|||||
|
2023
Q1 | $1.26M | Sell |
|
|||||
|
2022
Q4 | $2.19M | Buy |
|
|||||
|
2022
Q3 | $2.25M | Buy |
|
|||||
|
2022
Q2 | $369K | Sell |
|
|||||
|
2022
Q1 | $1.58M | Sell |
|
|||||
|
2021
Q4 | $2.2M | Sell |
|
|||||
|
2021
Q3 | $2.83M | Buy |
|
|||||
|
2021
Q2 | $1.36M | Sell |
|
|||||
|
2021
Q1 | $2.4M | Buy |
|
|||||
|
2020
Q4 | $1.84M | Sell |
|
|||||
|
2020
Q3 | $1.98M | Sell |
|
|||||
|
2020
Q2 | $3.27M | Sell |
|
|||||
|
2020
Q1 | $2.92M | Sell |
|
|||||
|
2019
Q4 | $7.65M | Buy |
|
|||||
|
2019
Q3 | $2.17M | Sell |
|
|||||
|
2019
Q2 | $3.51M | Sell |
|
|||||
|
2019
Q1 | $4.76M | Buy |
|
|||||
|
2018
Q4 | $1.46M | Buy |
|
|||||
|
2018
Q3 | $2.55M | Buy |
|
|||||
|
2018
Q2 | $1.28M | Sell |
|
|||||
|
2018
Q1 | $614K | Buy |
|
|||||
|
2017
Q4 | $521K | Buy |
|
|||||
|
2017
Q3 | $407K | Buy |
|
|||||
|
2017
Q2 | $196K | Buy |
|
|||||
|
2017
Q1 | $86K | Sell |
|
|||||
|
2016
Q4 | $103K | Buy |
|
|||||
|
2016
Q3 | $2K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $2K | Buy |
|